Opinion: 2022 could be the year for pharmaceutical marijuana
Despite the success of adult-use marijuana, 2022 is looking like the year pharmaceutical cannabis becomes a major market…
News March 21
Latest In: Canopy Growth
Cannabis producer Canopy Growth dropped from S&P/TSX 60 Index
Smiths Falls, Ontario-based cannabis producer Canopy Growth Corp. is being deleted from the S&P/TSX 60 Index.
News March 8
Court tosses Canopy cannabis patent infringement lawsuit against GW Pharma
A Texas court has dismissed a lawsuit brought by Canadian cannabis producer Canopy Growth against GW Pharmaceuticals, although…
News March 2
Canada’s cannabis legalization review running late, as industry hopes for reforms
More than three years after Canada legalized and regulated recreational cannabis, the country's legalization law is overdue for…
News February 25
Health Canada seized more than 35M grams of marijuana, 7,800 plants after inspections
Health Canada seized more than 35 million grams (77,162 pounds) of cannabis products and thousands of plants from…
News February 23
Canopy Growth loses CA$115 million in quarter on lower cannabis sales
Canopy Growth reported a net loss of 115 million Canadian dollars ($90 million) in its quarter ended Dec.…
News February 9
Canopy vows to ‘forge forward,’ says no mold issues in marijuana greenhouses
An executive at Canadian licensed producer Canopy Growth acknowledged that images circulating on social media depicting cannabis plants…
News February 3
Key hearing begins in $600 million lawsuit against marijuana MSO Acreage
A New York state judge started hearing a case Tuesday on whether a Syracuse investor group can proceed…
News January 18
Organigram loss narrows on brisk cannabis sales
New Brunswick cannabis producer Organigram’s loss narrowed to 1.3 million Canadian dollars ($1 million) as adult-use sales soared…
News January 11Featured
1
Latest Sponsored
